Mark Treherne

Commercial research scientist with 30 years%27 experience in the discovery of novel treatments for and the diagnosis of diseases with unmet medical needs. Now served on the boards of multiple therapeutics, research services, research tools and diagnostics companies worldwide. Worked with teams to out licence therapeutic assets over the last 25 years for upfront payments, milestones and future royalties exceeding £1.5 billion.

Specialties:
• outlicensing therapeutic assets
• technical due diligence
• mergers and acquisitions
• advice on fundraising strategies
• R&D strategy and management
• outsourcing and contract pricing
• business development
• inward investment strategies
• grant appraisals and revisions
• technical and commercial training